Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Mar 21, 2024

BUY
$31.31 - $44.19 $1.03 Million - $1.46 Million
33,000 New
33,000 $1.39 Million
Q2 2022

Aug 11, 2022

SELL
$3.38 - $5.65 $315,354 - $527,145
-93,300 Closed
0 $0
Q1 2022

May 12, 2022

SELL
$5.06 - $8.77 $156,860 - $271,870
-31,000 Reduced 24.94%
93,300 $514,000
Q4 2021

Feb 11, 2022

SELL
$7.33 - $9.32 $3.24 Million - $4.13 Million
-442,700 Reduced 78.08%
124,300 $1.06 Million
Q3 2021

Nov 10, 2021

BUY
$7.01 - $11.37 $2.32 Million - $3.77 Million
331,400 Added 140.66%
567,000 $4.93 Million
Q2 2021

Aug 12, 2021

BUY
$9.4 - $16.85 $2.21 Million - $3.97 Million
235,600 New
235,600 $2.49 Million

Others Institutions Holding IMVT

About Immunovant, Inc.


  • Ticker IMVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,077,000
  • Market Cap $3.55B
  • Description
  • Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...
More about IMVT
Track This Portfolio

Track Healthcare Of Ontario Pension Plan Trust Fund Portfolio

Follow Healthcare Of Ontario Pension Plan Trust Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Healthcare Of Ontario Pension Plan Trust Fund, based on Form 13F filings with the SEC.

News

Stay updated on Healthcare Of Ontario Pension Plan Trust Fund with notifications on news.